Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) CEO Vininder Singh sold 27,958 shares of the stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $1.44, for a total value of $40,259.52. Following the completion of the transaction, the chief executive officer now directly owns 2,348,341 shares of the company’s stock, valued at $3,381,611.04. This trade represents a 1.18 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Vininder Singh also recently made the following trade(s):
- On Tuesday, April 1st, Vininder Singh sold 7,245 shares of Bullfrog AI stock. The stock was sold at an average price of $1.61, for a total value of $11,664.45.
Bullfrog AI Stock Down 7.8 %
Shares of NASDAQ BFRG opened at $1.30 on Friday. The firm’s 50-day simple moving average is $2.28 and its 200 day simple moving average is $2.34. The stock has a market cap of $12.24 million, a P/E ratio of -1.53 and a beta of 0.33. Bullfrog AI Holdings, Inc. has a fifty-two week low of $1.23 and a fifty-two week high of $4.84.
Institutional Investors Weigh In On Bullfrog AI
A number of institutional investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new stake in shares of Bullfrog AI in the 4th quarter worth $30,000. Two Sigma Securities LLC acquired a new position in shares of Bullfrog AI in the 4th quarter worth approximately $41,000. Finally, Geode Capital Management LLC raised its holdings in shares of Bullfrog AI by 31.0% in the 4th quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock worth $94,000 after purchasing an additional 11,140 shares in the last quarter. 0.96% of the stock is currently owned by institutional investors and hedge funds.
Bullfrog AI Company Profile
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Featured Stories
- Five stocks we like better than Bullfrog AI
- What Are Dividend Contenders? Investing in Dividend Contenders
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Conference Calls and Individual Investors
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.